[go: up one dir, main page]

GB0801513D0 - Peptides from factor VIII - Google Patents

Peptides from factor VIII

Info

Publication number
GB0801513D0
GB0801513D0 GBGB0801513.3A GB0801513A GB0801513D0 GB 0801513 D0 GB0801513 D0 GB 0801513D0 GB 0801513 A GB0801513 A GB 0801513A GB 0801513 D0 GB0801513 D0 GB 0801513D0
Authority
GB
United Kingdom
Prior art keywords
peptides
factor viii
viii
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0801513.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Circassia Ltd
Original Assignee
Circassia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Circassia Ltd filed Critical Circassia Ltd
Priority to GBGB0801513.3A priority Critical patent/GB0801513D0/en
Publication of GB0801513D0 publication Critical patent/GB0801513D0/en
Priority to PCT/GB2009/000187 priority patent/WO2009095646A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/755—Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GBGB0801513.3A 2008-01-28 2008-01-28 Peptides from factor VIII Ceased GB0801513D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0801513.3A GB0801513D0 (en) 2008-01-28 2008-01-28 Peptides from factor VIII
PCT/GB2009/000187 WO2009095646A2 (en) 2008-01-28 2009-01-23 Peptides from factor viii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0801513.3A GB0801513D0 (en) 2008-01-28 2008-01-28 Peptides from factor VIII

Publications (1)

Publication Number Publication Date
GB0801513D0 true GB0801513D0 (en) 2008-03-05

Family

ID=39186435

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0801513.3A Ceased GB0801513D0 (en) 2008-01-28 2008-01-28 Peptides from factor VIII

Country Status (2)

Country Link
GB (1) GB0801513D0 (en)
WO (1) WO2009095646A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0908515D0 (en) * 2009-05-18 2009-06-24 Apitope Technology Bristol Ltd Peptide
NZ609474A (en) * 2010-10-27 2015-06-26 Baxter Healthcare Sa Fviii peptides for immune tolerance induction and immunodiagnostics
LT2917232T (en) * 2012-11-12 2017-06-26 Apitope International Nv Factor viii-derived peptides for use in the treatment of haemophilia a
JP2016534083A (en) * 2013-10-22 2016-11-04 デベヴェ・テクノロジーズ Methods for treating hemophilia by inducing tolerance to blood factors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020068303A1 (en) * 1994-07-14 2002-06-06 Ruth Laub Antigenic polypeptide sequences of factor VIII, and fragments and/or epitopes of these sequences
AU2002249779A1 (en) * 2000-12-01 2002-08-12 Regents Of The University Of Minnesota Method to treat hemophilia
WO2003087161A1 (en) * 2002-04-18 2003-10-23 Merck Patent Gmbh Modified factor viii
GB0723712D0 (en) * 2007-12-04 2008-01-16 Apitope Technology Bristol Ltd Peptides

Also Published As

Publication number Publication date
WO2009095646A3 (en) 2010-03-11
WO2009095646A2 (en) 2009-08-06

Similar Documents

Publication Publication Date Title
EP2344648A4 (en) Recombinant vectors
GB0914110D0 (en) Peptide libraries
PT2310034E (en) Peptides for treating beta-amyloidoses
IL209585A0 (en) Angiopoietin derived peptides
GB0723712D0 (en) Peptides
IL202120A0 (en) Signaling peptides
ZA201000283B (en) Reinigung pegylierter polypeptide
ZA201001451B (en) Immunomodulatory peptides
GB0920981D0 (en) Peptides
EP2123666A4 (en) Peptide
ZA201108446B (en) FViII-DERIVED PEPTIDES
HK1155762A1 (en) Highly bridged peptides from actinomadura namibiensis actinomadura namibiensis
GB0801513D0 (en) Peptides from factor VIII
ZA201203722B (en) Peptide
HK1152717A1 (en) Angiogenic peptide
EP2188305A4 (en) Modified peptides having toxin-enhancing effects
EP2254901A4 (en) Therapeutic peptides
GB0703945D0 (en) Peptide
EP2136831A4 (en) Anti-angiogenic peptides
GB0809659D0 (en) Polypeptides
GB0920987D0 (en) Peptides
IL197675A0 (en) Peptides
GB0708529D0 (en) Peptide standards
GB0817978D0 (en) Peptides
GB0812586D0 (en) Chimaeric peptide

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)